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Background
Robust and reliable dynamic bioreactors for long term
maintenance of various tissues at milliliter-scale on the
basis of a biological, vascularized matrix (BioVaSc®)
have been developed at the Fraunhofer IGB in Stuttgart,
Germany. As an intestinal in vitro equivalent, seeding of
the matrix with CaCo-2 cells yielded in the self-assem-
bly of a microenvironment with the typical histological
appearance of villus-like structure and morphology [1].
We modified this matrix (BioVaSc®) - cell (CaCo-2) sys-
tem to some extent with the aim to develop 3D intest-
inal equivalents for systemic preclinical testing of orally
applied drug candidates in microliter-scale on a human
Multi-Organ-Chip (MOC), which consists of different
organ equivalents important for ADMET (adsorption,
distribution, metabolism, excretion, toxicity) testing.
Materials and methods
For the generation of biological, vascularized matrices
(rBioVaSc®), jejunal segments of the small intestine of
Wistar rats including the corresponding capillary bed
were explanted and decellularized by perfusion with 1%
sodium deoxycholate. Characterization of the matrix
was done by histological analysis as well as 2-photon
microscopy (2 PM) and immunofluorescent stainings.
After sterilization by g-irradiation, the rBioVaSc® could
be used to built up a 3D intestinal equivalent. Punch
biopsies of the matrix were fixed on the frame of a
96-well transwell insert and seeded with CaCo-2 cells
(2*10^6 cells) on the former luminal side of the matrix
following static cultivation for 48 hours and integration
in a perfused MOC device. Our MOC device consists of
an integrated micro-pump, a microfluidic channel sys-
tem and inserts for the cultivation of different organ
equivalents (Figure 1e). For the generation of the intest-
inal equivalent, the generated matrix-cell construct was
placed in the MOC device and perfused for up to one
week with cell culture medium (supplemented MEM),
following histological as well as immunofluorescence
(IF) analysis of the growth behavior of the cells. As a
control, matrix-cell constructs were cultivated statically.
Daily medium samples have been analyzed to monitor
metabolic activity and the absorption properties of the
intestinal equivalent. Immunohistostaining of cryo-
preserved tissue slices have been analyzed to compare
self-assembled organoid tissue structures with their
corresponding in vivo counterparts.
Results
Decellularization of jejunal segments of rats together
with the corresponding capillary bed yielded in a
biological, vascularized matrix which was free of
non-human cells but with the preserved 3D structure
of the former intestinal extracellular matrix (ECM)
(Figure 1a-d). Those ECM components were used for
the resettlement of human intestinal cells (CaCo-2)
which resulted in the formation of characteristical
villus-like structures on the matrix after one week of
perfused cultivation (Figure 1f+g). Cells expressed typi-
cal intestinal epithelial markers, e.g. CK8/18, EpCAM
and Na/K-ATPase. Process parameters, such as nutri-
ent perfusion rate and culture time, have been opti-
mized to qualify the system for repeated dose testing
of orally administered drug candidates.
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Conclusions
As shown by histological as well as immunofluorescent
stainings, we succeeded in the development of self-
assembled 3D organ equivalents which have a character-
istical intestinal architecture. Those organ equivalents
can be used as an in vitro system for the evaluation of
adsorption properties of orally administered drugs in
microliter-scale on a multi-organ-chip (MOC). Further
improvements of the MOC device are necessary, e.g. the
integration of a second circulation, representing the
intestinal lumen. In addition, reseeding the matrix with
primary intestinal cells as well as co-cultures of epithe-
lial and endothelial cells are planned.
Acknowledgements
The work has been funded by the German Federal Ministry for Education
and Research, GO-Bio Grand No. 0315569.
Authors’ details
1TU Berlin, Institute for Biotechnology, Faculty of Process Science and
Engineering, 13355 Berlin, Germany. 2TissUse GmbH, 15528 Spreenhagen,
Germany. 3Fraunhofer Institute for Interfacial Engineering and Biotechnology
IGB, 70569 Stuttgart, Germany. 4Chair of Tissue Engineering and
Regenerative Medicine, Julius-Maximilians-Universität Würzburg, 97070
Würzburg, Germany.
Published: 4 December 2013
Reference
1. Pusch J, Votteler M, Göhler S, Engl J, Hampel M, Walles H, Schenke-
Layland K: The physiological performance of a three-dimensional model
that mimics the microenvironment of the small intestine. Biomaterials
2011, 32:7469-7478.
doi:10.1186/1753-6561-7-S6-P65
Cite this article as: Jaenicke et al.: Development of 3D human intestinal
equivalents for substance testing in microliter-scale on a multi-organ-
chip. BMC Proceedings 2013 7(Suppl 6):P65.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Figure 1 a-d) Characterization of the decellularization procedure. a) Explanted jejunal segment with the preserved capillary bed after
decellularization. b) H/E staining of the decellularized matrix. c) Feulgen staining of the decellularized matrix. d) immunofluorescent stainings for
collagen I on rBioVaSc. e) The multi-organ-chip (MOC) device consisting of an integrated micro-pump, a microfluidic .channel system and inserts
for the cultivation of different organ equivalents. f+g) Characterization of the intestinal in vitro equivalent. f) H/E staining of the recellularized
matrix after one week of dynamic culture in the MOC device. g) Second Harmonic Generation by 2 PM, nuceli were stained with Hoechst 33342.
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